Recall events
/
Event 84055
Event summary
Timeline bucket October 15, 2019
Product types Drug
Classifications Class II
Statuses Terminated
Recalling firm wording 8046255 Canada Inc. DBA Viatrexx
Dossier provenance
Source snapshots represented here
openFDA Drug Enforcement
Report-date coverage
June 20, 2012–July 08, 2026
Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.
How coverage and grouping work
Device root-cause evidence is not applicable to this event.
No grouped product has the official product type device; this is not an unavailable-enrichment finding.
Complete imported group
Every recalled product in this event
23 official enforcement rows
Product dates, classifications, firms, and source wording remain attached to their individual rows.
Opening this dossier never hides products that did not match a prior timeline filter.
drug · product 1 of 23
Viatrexx-Connectissue, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0090, NDC 73069-100-41.
D-0326-2020
Recall number D-0326-2020
Initiated October 15, 2019
Classification Class II
Status Terminated
Quantity 24 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Code information Lot Numbers: 19-S00001, Exp. May: 2020
Distribution pattern Distributed to physicians Nationwide throughout the United States and Puerto Rico.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11592]
FDA event record
· Exact recall-number query on openFDA
drug · product 2 of 23
Viatrexx-MuSkel-Neural, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC4020, NDC 73069-347-41.
D-0327-2020
Recall number D-0327-2020
Initiated October 15, 2019
Classification Class II
Status Terminated
Quantity 61 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Code information Lot Numbers: 19-S00002, Exp. May: 2020
Distribution pattern Distributed to physicians Nationwide throughout the United States and Puerto Rico.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11610]
FDA event record
· Exact recall-number query on openFDA
drug · product 3 of 23
Viatrexx-Ouch, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0500, NDC 73069-402-41.
D-0328-2020
Recall number D-0328-2020
Initiated October 15, 2019
Classification Class II
Status Terminated
Quantity 19 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Code information Lot Numbers: 19-S00003, Exp. May: 2020
Distribution pattern Distributed to physicians Nationwide throughout the United States and Puerto Rico.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11492]
FDA event record
· Exact recall-number query on openFDA
drug · product 4 of 23
Viatrexx-Ithurts, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0290, NDC 73069-270-41.
D-0329-2020
Recall number D-0329-2020
Initiated October 15, 2019
Classification Class II
Status Terminated
Quantity 12 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Code information Lot Numbers: 19-S00004, Exp. May: 2020
Distribution pattern Distributed to physicians Nationwide throughout the United States and Puerto Rico.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11877]
FDA event record
· Exact recall-number query on openFDA
drug · product 5 of 23
Viatrexx-Adipose, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0008, NDC 73069-024-41.
D-0330-2020
Recall number D-0330-2020
Initiated October 15, 2019
Classification Class II
Status Terminated
Quantity 4 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Code information Lot Numbers: 19-S00005, Exp. May: 2020
Distribution pattern Distributed to physicians Nationwide throughout the United States and Puerto Rico.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11620]
FDA event record
· Exact recall-number query on openFDA
drug · product 6 of 23
Viatrexx-Systemic Detox, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0665, NDC 73069-500-41.
D-0331-2020
Recall number D-0331-2020
Initiated October 15, 2019
Classification Class II
Status Terminated
Quantity 5 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Code information Lot Numbers: 19-S00007, Exp. May: 2020
Distribution pattern Distributed to physicians Nationwide throughout the United States and Puerto Rico.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11841]
FDA event record
· Exact recall-number query on openFDA
drug · product 7 of 23
Viatrexx-Articula, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0031, NDC 73069-037-41.
D-0332-2020
Recall number D-0332-2020
Initiated October 15, 2019
Classification Class II
Status Terminated
Quantity 69 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Code information Lot Numbers: 19-S00008, Exp. May: 2020
Distribution pattern Distributed to physicians Nationwide throughout the United States and Puerto Rico.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11824]
FDA event record
· Exact recall-number query on openFDA
drug · product 8 of 23
Viatrexx-Neuro 3, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0463, NDC 73069-373-41.
D-0333-2020
Recall number D-0333-2020
Initiated October 15, 2019
Classification Class II
Status Terminated
Quantity 7 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Code information Lot Numbers: 19-S00010, Exp. May: 2020
Distribution pattern Distributed to physicians Nationwide throughout the United States and Puerto Rico.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11834]
FDA event record
· Exact recall-number query on openFDA
drug · product 9 of 23
Viatrexx-Infla, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0279, NDC 73069-249-41.
D-0334-2020
Recall number D-0334-2020
Initiated October 15, 2019
Classification Class II
Status Terminated
Quantity 54 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Code information Lot Numbers: 19-S00012, Exp. May: 2020
Distribution pattern Distributed to physicians Nationwide throughout the United States and Puerto Rico.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11863]
FDA event record
· Exact recall-number query on openFDA
drug · product 10 of 23
Viatrexx-Collagen, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0085, NDC 73069-095-41.
D-0335-2020
Recall number D-0335-2020
Initiated October 15, 2019
Classification Class II
Status Terminated
Quantity 22 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Code information Lot Numbers: 19-S00014, Exp. May: 2020
Distribution pattern Distributed to physicians Nationwide throughout the United States and Puerto Rico.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11826]
FDA event record
· Exact recall-number query on openFDA
drug · product 11 of 23
Viatrexx-Prolo, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0558, NDC 73069-443-41.
D-0336-2020
Recall number D-0336-2020
Initiated October 15, 2019
Classification Class II
Status Terminated
Quantity 42 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Code information Lot Numbers: 19-S00016, Exp. May: 2020
Distribution pattern Distributed to physicians Nationwide throughout the United States and Puerto Rico.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11853]
FDA event record
· Exact recall-number query on openFDA
drug · product 12 of 23
Viatrexx-Lymph 1, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0370, NDC 73069-310-41.
D-0337-2020
Recall number D-0337-2020
Initiated October 15, 2019
Classification Class II
Status Terminated
Quantity 3 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Code information Lot Numbers: 19-S00017, Exp. May: 2020
Distribution pattern Distributed to physicians Nationwide throughout the United States and Puerto Rico.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11827]
FDA event record
· Exact recall-number query on openFDA
drug · product 13 of 23
Viatrexx-Mesenchyme, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0092, NDC 73069-102-41.
D-0338-2020
Recall number D-0338-2020
Initiated October 15, 2019
Classification Class II
Status Terminated
Quantity 7 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Code information Lot Numbers: 19-S00018, Exp. May: 2020
Distribution pattern Distributed to physicians Nationwide throughout the United States and Puerto Rico.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11871]
FDA event record
· Exact recall-number query on openFDA
drug · product 14 of 23
Viatrexx-GI, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0211, NDC 73069-189-41.
D-0339-2020
Recall number D-0339-2020
Initiated October 15, 2019
Classification Class II
Status Terminated
Quantity 3 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Code information Lot Numbers: 19-S00019, Exp. May: 2020
Distribution pattern Distributed to physicians Nationwide throughout the United States and Puerto Rico.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11837]
FDA event record
· Exact recall-number query on openFDA
drug · product 15 of 23
Viatrexx-Arthros, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0030, NDC 73069-035-41.
D-0340-2020
Recall number D-0340-2020
Initiated October 15, 2019
Classification Class II
Status Terminated
Quantity 6 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Code information Lot Numbers: 19-S00021, Exp. May: 2020
Distribution pattern Distributed to physicians Nationwide throughout the United States and Puerto Rico.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11504]
FDA event record
· Exact recall-number query on openFDA
drug · product 16 of 23
Viatrexx-Immunexx, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0270, NDC 73069-244-41.
D-0341-2020
Recall number D-0341-2020
Initiated October 15, 2019
Classification Class II
Status Terminated
Quantity 18 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Code information Lot Numbers: 19-S00023, Exp. May: 2020
Distribution pattern Distributed to physicians Nationwide throughout the United States and Puerto Rico.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11593]
FDA event record
· Exact recall-number query on openFDA
drug · product 17 of 23
Viatrexx-Relief +, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0615, NDC 73069-450-41.
D-0342-2020
Recall number D-0342-2020
Initiated October 15, 2019
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Code information Lot Numbers: 19-S00024, Exp. May: 2020
Distribution pattern Distributed to physicians Nationwide throughout the United States and Puerto Rico.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11864]
FDA event record
· Exact recall-number query on openFDA
drug · product 18 of 23
Viatrexx-Intra-Cell, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0280, NDC 73069-250-41.
D-0343-2020
Recall number D-0343-2020
Initiated October 15, 2019
Classification Class II
Status Terminated
Quantity 8 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Code information Lot Numbers: 19-S00025, Exp. May: 2020
Distribution pattern Distributed to physicians Nationwide throughout the United States and Puerto Rico.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11485]
FDA event record
· Exact recall-number query on openFDA
drug · product 19 of 23
Viatrexx-Facial, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0184, NDC 73069-164-41.
D-0344-2020
Recall number D-0344-2020
Initiated October 15, 2019
Classification Class II
Status Terminated
Quantity 13 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Code information Lot Numbers: 19-S00026, Exp. May: 2020
Distribution pattern Distributed to physicians Nationwide throughout the United States and Puerto Rico.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11848]
FDA event record
· Exact recall-number query on openFDA
drug · product 20 of 23
Viatrexx-Hair, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0251, NDC 73069-206-41.
D-0345-2020
Recall number D-0345-2020
Initiated October 15, 2019
Classification Class II
Status Terminated
Quantity 3 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Code information Lot Numbers: 19-S00009, Exp. May: 2020
Distribution pattern Distributed to physicians Nationwide throughout the United States and Puerto Rico.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11796]
FDA event record
· Exact recall-number query on openFDA
drug · product 21 of 23
Viatrexx-Neuro, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0460, NDC 73069-375-41.
D-0346-2020
Recall number D-0346-2020
Initiated October 15, 2019
Classification Class II
Status Terminated
Quantity 13 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Code information Lot Numbers: 19-S00020, Exp. May: 2020
Distribution pattern Distributed to physicians Nationwide throughout the United States and Puerto Rico.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11872]
FDA event record
· Exact recall-number query on openFDA
drug · product 22 of 23
Viatrexx-Male+, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0400, NDC 73069-320-41.
D-0347-2020
Recall number D-0347-2020
Initiated October 15, 2019
Classification Class II
Status Terminated
Quantity 2 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Code information Lot Numbers: 19-S00022, Exp. May: 2020
Distribution pattern Distributed to physicians Nationwide throughout the United States and Puerto Rico.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11512]
FDA event record
· Exact recall-number query on openFDA
drug · product 23 of 23
Viatrexx-ANS/CNS, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0025, NDC 73069-039-41.
D-0348-2020
Recall number D-0348-2020
Initiated October 15, 2019
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Code information Lot Numbers: 19-S00027, Exp. May: 2020
Distribution pattern Distributed to physicians Nationwide throughout the United States and Puerto Rico.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11799]
FDA event record
· Exact recall-number query on openFDA